Viruses interact with hundreds to thousands of proteins in mammals, yet adaptation 6 against viruses has only been studied in a few proteins specialized in antiviral defense.
3 viruses have driven a substantial proportion of all adaptations across the human and 1 mammalian proteomes, establishing that the war against viruses does indeed affect the 2 proteome as a whole.
3
We finally showcase the power of our global scan for adaptation in VIPs by studying the 4 case of aminopeptidase N, a well-known multifunctional enzyme (Mina-Osorio, 2008) 5 used by coronaviruses as a receptor (Delmas et al., 1992; Yeager et al., 1992) . Using 6 our approach we reach an amino-acid level understanding of parallel adaptive evolution 7 in aminopeptidase N in response to coronaviruses in a wide range of mammals.
8
Results

9
Here we analyze patterns of both adaptive evolution and evolutionary 10 constraint/purifying selection in a large set of 1,256 manually curated VIPs from the low-11 throughput virology literature (Methods and Table S1 available online). We exclude 12 interactions identified by high-throughput experiments as we are concerned about a high 13 rate of false positives (Mellacheruvu et al., 2013). These 1,256 VIPs were annotated 14 from an initial set of 9,861 proteins with orthologs in 24 mammals with high quality 15 genomes ( Figure S1 , Table S2 and Methods). VIPs in our dataset interact with viral 16 proteins, viral RNA, or viral DNA. Most of them (95%) correspond to an interaction 17 between a human protein and a virus infecting humans (Table S1 ). Human
18
Immunodeficiency Virus type 1 (HIV-1) is the best-represented virus with 240 VIPs, with 19 nine other viruses having at least 50 VIPs (Table S1 ). Table S4 ). These 241 immune VIPs include the VIPs 2 classified as antiviral (Table S4 ) throughout this manuscript. In total, 162 overlapping GO 3 cellular and supracellular processes have more than 50 VIPs (Table S3 ). These 4 observations confirm that viruses interact with proteins involved in the majority of basic 5 cellular processes.
6
Patterns of purifying selection in VIPs 7
We confirm the observations of several recent studies suggesting that VIPs tend to 8 evolve slowly (Davis et al., 2015; Jager et al., 2012) . The VIPs have ~15% lower 9 mammals-wide dN/dS ratio on average compared to non-VIPs (0.124 versus 0.145, 95% 10 CI [0.136,0.148]; Methods). The difference in dN/dS is highly significant as shown by a 11 permutation test where VIPs are compared with the same number of randomly chosen 12 non-VIPs many times (simple permutation test P=0 after 10 9 iterations; Table S2 ).
13
To disentangle whether the slower evolution of VIPs is due to stronger purifying 14 selection or to a lower rate of adaptation, we use the ratio of non-synonymous 15 polymorphisms to synonymous polymorphisms pN/pS rather than the dN/dS ratio. Unlike 16 dN/dS that is strongly influenced by both the effects of purifying selection and 17 adaptation, pN/pS is primarily determined by the efficiency of purifying selection in 18 removing deleterious non-synonymous mutations.
19
Genome-wide polymorphisms required to measure pN/pS at the scale of the proteome 20 have become available for humans (Abecasis et al., 2012) (1,000 Genomes Project) 21 (Table S5) , and chimpanzee, gorilla, and orangutans (Prado-Martinez et al., 2013)
22
(Great Apes Genome Project) (Table S6 ). The 1,000 Genomes Project and the Great
23
Apes Genome Project are complementary for this analysis. On the one hand, the 1,000
24
Genomes Project provides high quality variants with frequencies estimated from a large 25 number of individuals. On the other hand the Great Ape Genome project includes fewer 26 individuals, but provides substantial pN and pS counts for more genes than the 1000 27 genomes data. This is because the great apes populations are more polymorphic than 28 modern human populations, and are less affected by the noise due to genetic drift and 29 strong bottlenecks. Thus, although the 1,000 genomes are well suited for approaches 30 requiring precise frequency estimates (such as the McDonald-Kreitman test 31 implemented below (Messer and Petrov, 2013)), the Great Ape genome data is well 32 5 suited for the estimation of the pN/pS ratio in as many proteins as possible. Specifically, 1 we measure pN/pS as the average across non-human great apes (or as the average in 2 the 1,000 Genomes African populations; Supplemental Methods) using the data from the 3 largest chimpanzee, gorilla, and orangutan populations in order to further limit the noise 4 in the estimation of the strength of purifying selection due to drift and bottlenecks (Prado-5 Martinez et al., 2013). We use only great ape pN and pS in the analyses that involve 6 subsamples of proteins in order to retain sufficient statistical power.
7
In human African populations from the 1,000 Genomes project (Supplemental Methods), 8 the average pN/pS is 21% lower in VIPs compared to non-VIPs (0.759 versus 0.966, 9 95% CI [0.92,1.01], simple permutation test P=0 after 10 9 iterations). This suggests that 10 in the human lineage VIPs have been under stronger purifying selection than non-VIPs.
11
In line with this, VIPs also show an excess of low frequency (≤10%) deleterious non-12 synonymous variants compared to non-VIPs ( Figure S3 ). In great apes, the average 13 pN/pS ratio is 25% lower in VIPs compared to non-VIPs (0.526 versus 0.697, 95% CI
14
[0.66,0.72], simple permutation test P=0 after 10 9 iterations). The distribution of pN/pS in 15 VIPs is globally skewed towards lower values compared to non-VIPs ( Figure 1A ). The 16 difference in pN/pS in great apes between VIPs and non-VIPs is robust to a number of 17 potentially confounding factors, including gene length, GC content and recombination 18 (Table S7 ). These results show that VIPs do experience stronger purifying selection than 19 non-VIPs. Finally, stronger purifying selection acting on the VIPs is widespread and is 20 not limited to VIPs interacting with any one particular virus ( Figure 1B ).
21
The higher level of purifying selection in VIPs might be due to the fact that VIPs 22 participate in the more constrained host functions, or, alternatively, because within each 23 specific host function, viruses tend to interact with the more constrained proteins. In 24 order to assess these two non-mutually exclusive scenarios we generated 10 4 control 25 sets of non-VIPs chosen to be in the same 162 Gene Ontology processes as VIPs (GO 26 processes with more than 50 VIPs; Table S3 and Methods).
27
In great apes, GO-matched non-VIPs still have a much higher pN/pS ratio compared to 28 VIPs, suggesting that VIPs tend to be more conserved than non-VIPs from the same GO 29 category. On average, pN/pS in the GO-matched non-VIPs is 0.647 (95% CI
30
[0.621,0.674]). This is only slightly lower than the average ratio in non-VIPs in general 31 (pN/pS=0.697, P=2x10 -3 ), but much higher than the average ratio in VIPs (0.526, 32 6 permutation test P=0 after 10 9 iterations). The stronger purifying selection acting on VIPs 1 is apparent within most functions. Figure 1C shows stronger purifying selection in the 20 2 high level GO categories with the most VIPs. In all the 20 GO categories pN/pS is lower 3 in VIPs than in non-VIPs, and the difference is significant for 17 of these categories 4 (Table S3 ). This shows that within a wide range of host functions, viruses tend to target 5 the most conserved proteins.
6
Interestingly, even immune VIPs (Table S4 ) have a significantly reduced pN/pS ratio 7 compared to immune non-VIPs ( Figure 1C ), which suggests that immune proteins in 8 direct contact with viruses are more constrained. The reduction in pN/pS in non-immune 9 VIPs (no antiviral or any other immune function, Table S4 ) is very similar to the reduction 10 observed in the entire set of VIPs ( Figure 1C ). The classic MK test is known to be biased downward by the presence of slightly 1 deleterious non-synonymous variants and this bias is difficult to eliminate fully even by 2 excluding low frequency variants (Messer and Petrov, 2013). Note that our application 3 of the classic MK test to discover the higher rate of adaptation in VIPs compared to non-4 VIPs is conservative given that the VIPs have a higher proportion of slightly deleterious 5 non-synonymous variants and thus should show a stronger downward bias in the 6 estimation of α ( Figure S3 ). However, the nominal estimates of α=0.19 and -0.02 in VIPs 7 and non-VIPs are likely underestimates of the true proportions of adaptive amino acid 8 changes.
9
We therefore apply an asymptotic modification of the MK test known to provide 10 estimates of α without a downward bias in the presence of slightly deleterious variants 11 (Messer and Petrov, 2013) . To further validate the asymptotic MK test we carry out 12 extensive population simulations (Messer, 2013) to show that this test is indeed robust to 13 a number of potential biases (Supplemental Methods and Table S8 ).
14 Using the asymptotic MK test we estimate that in VIPs, ~27% of the 1,897 amino acid 15 substitutions along the human lineage were adaptive ( Figure 1D ). This proportion is 16 three times higher than the estimated proportion of ~9% in non-VIPs ( Figure 1D ). Thus,
17
although VIPs represent only 13% of the orthologs in our dataset, we estimate that in 
21
The high α in VIPs is not explained by higher rates of adaptation in the host GO 22 processes where VIPs are well represented ( Figure S4 and Methods). Furthermore, the 23 large difference in α observed between VIPs and non-VIPs is robust to a number of 24 potentially confounding factors such as recombination, GC content or gene length (Table   25 S9 and Supplemental Methods). The lower pN/pS in VIPs does not explain their higher α 26 either (Table S9 ).
27
We further use the classic MK test (excluding variants below 10%) to investigate the 28 excess of adaptation for the specific VIPs of ten human viruses and in the 20 high level
29
GO categories with the most VIPs ( Figure 1E 
5
Finally and importantly, the 80% of VIPs with no known antiviral or broader immune 6 function (Table S4 ) have a strongly increased rate of adaptation according to both the 7 classic MK test (α=0.26 in VIPs versus -0.02 in non-VIPs, permutation test P=3x10 -7 ; 8 Figure 1F ) and the asymptotic MK test, with the latter estimating α=38% in non-immune 9 VIPs against only 11% for non-immune non-VIPs. Intriguingly, unlike for non-immune 10 VIPs or all VIPs considered together (top of Figure 1F ), immune VIPs, including antiviral 11 VIPs (Table S4) , do not show any increase of adaptation compared to immune non-
12
VIPs. We speculate that this pattern might reflect the masking effect of balancing The increased rate of adaptation in VIPs in the human lineage strongly suggests that 20 VIPs in our dataset, 95% of which interact with modern viruses (Table S1 ), were also 21 VIPs during past human evolution. It is also plausible that a substantial proportion of the 22 VIPs we study are also VIPs in multiple mammalian lineages. Indeed, viruses infecting 
11
The product of P-values is a good measure of whether a specific protein experienced 12 adaptation in the history of mammalian evolution. In addition to presence/absence of 13 adaptation, we assess the amount of adaptation experienced by a particular protein by 14 estimating the average proportion of selected codons along all mammalian branches.
15
For example we measure that on average the antiviral protein PKR has had 4.6% of 16 positively selected codons across the 44 branches of the mammalian tree.
17
We compare the proportion of selected codons detected by the BS-REL test between 
28
The purifying selection-wise permutation test shows that adaptation has been much 29 more common in VIPs than in non-VIPs across mammals ( Figure 2 ). We estimate that
30
VIPs have experienced 77% more adaptation compared to non-VIPs (Figure 2A) . In 31 total, this represents ~76,000 more adaptive amino acid changes in VIPs compared to 32 10 non-VIPs. We further use an increasingly strict level of evidence for the presence of 1 adaptation, by including only proteins with increasingly low products of P-values; that is, 2 increasingly low probability that no adaptation occurred (Figure 2A ). Figure 2A shows 3 that VIPs with the strongest evidence of adaptation (product of P-values lower than 10 -9 ) 4 have a ~200% excess of strong signals of adaptation. This excess of adaptation in VIPs 5 across mammals is due to i) more VIPs with signals of adaptation than non-VIPs, ii) 6 more branches of the tree per VIP showing adaptation, and iii) a greater proportion of 7 codons evolving adaptively per branch ( Figure S7 ). 
16
GO processes with a strong excess of adaptation include cellular processes such as 17 transcription, signal transduction, apoptosis, or post-translational protein modification, 18 but also supracellular processes related to development ( Figure 2C and Table S3 ).
19
Importantly, VIPs with no known immune function (Table S4) show a 40% excess of 20 adaptation, and a ~130% excess of adaptation in the proteins with the highest evidence 21 of adaptation ( Figure 2A) . These results show that the arms race with viruses has 22 strongly increased the rate of adaptation in a wide range of VIPs.
23
Since 95% of the VIPs were discovered for viruses infecting humans, it is possible that 24 the observed excess of adaptation in VIPs in mammals is due to higher rates of 25 adaptation exclusively in the primate branches of the mammalian tree ( Figure S1 ).
26
However, all mammalian clades in the tree show a similar excess of adaptation in VIPs 27 ( Figure 2D ). Primates stand out due to their low overall proportions of positively selected 28 codons compared to the other mammalian clades in the tree ( Figure 2D ). This is most show such signals in all the mammalian clades represented (Figure 3 ). This includes well-known antiviral VIPs ( Figure 3A) , antiviral VIPs where adaptation was previously 1 unknown ( Figure 3B ), and non-antiviral VIPs with diverse, well-studied functions in the 2 mammalian hosts ( Figure 3C ). This phylogenetically widespread excess of adaptation 3 implies that many of the VIPs annotated in humans were also VIPs for a substantial 
15
To identify a new non-antiviral protein we first exclude all VIPs with a well-known 16 antiviral activity (Table S4 ) and then select all remaining VIPs with strong overall 17 evidence of adaptation (Table S10 ) and at least 10 branches with signals of adaptation.
18
Because we want to understand how adaptation to viruses proceeded, we then select 19 proteins with i) at least one available tertiary structure, ii) amino acid level resolution of 20 the interaction with one or more viruses, and iii) host tropism.
21
The most positively selected non-antiviral VIP that fulfills all these requirements is 22 aminopeptidase N, abbreviated ANPEP, APN or CD13 (Mina-Osorio, 2008). The 23 analysis of a phylogenetic tree including 84 mammals (Table S11) Figure 4C ). This enrichment fades very rapidly as one gets further from the surface of 16 contact with TGEV and PRCV, which shows that it is due to the interaction with viruses, 17 and not to a more diffuse, less specific enrichment within a wider segment of ANPEP 18 ( Figure 4C ).
19
Adaptively evolving codons in the contact surface with TGEV and PRCV most notably 20 include two codons within the consensus motif for the N-glycosylation site responsible 21 for host tropism ( Figure 4B ). N-glycosylation is governed by a three amino acids Figure 4D ). The consensus was regained only two times after loss 28 ( Figure 4D ). This means that the signals of adaptation detected at the first and third Figure 2C and Table S3 ). Our results thus draw a broader picture 12 where the war against viruses is a global war that involves not only the specialized 13 soldiers of the antiviral response, but also the entire population of host proteins that 
17
Although we already find a strong signal of increased adaptation, the amount of adaptive 18 evolution that can be attributed to viruses is probably underestimated by our analysis.
19
First, there may still be many undiscovered VIPs. Within the past few years, there has 20 been no sign that the pace of discovery of new VIPs is slowing down ( Figure S2 ). A 21 slowdown would happen if we were getting close to the point where only few, hard to 22 discover VIPs remain to be found. This means that a substantial number of proteins 23 classified as non-VIPs in this analysis actually are VIPs. This makes the current non-
24
VIPs a conservative control.
25
Second, adaptation in response to viruses is most likely not restricted to proteins that 26 physically interact with viruses. For example, adaptation to viruses might happen in 27 proteins that act downstream of VIPs in signaling cascades, or in non-coding sequences 28 that regulate the expression of VIPs.
29
Third, not all of the 1,256 VIPs we use here have been consistently interacting with 30 viruses during evolution. Most VIPs in the dataset (95%) were discovered in humans, and how frequently these VIPs have also been interacting with viruses in other mammals 1 is currently unknown. Some VIPs like PKR have probably been in very frequent contact 2 with diverse viruses. Conversely, other VIPs may have been in contact with viruses for a 3 very limited evolutionary time in mammals, and only in a limited range of lineages. This 4 would apply to VIPs that interact with viruses with a limited host range and few other 5 phylogenetically closely related viruses, as is the case with HCV ( Figure 2B ). host? We show that there has been so much adaptation in VIPs that it is very hard to 23 imagine that none of these adaptive events had any consequences on host phenotypes.
24
Interestingly, VIPs tend to be multifunctional proteins. Indeed they represent 13% of all 25 the orthologs in the analysis, 33% of the orthologs with 60 or more annotated GO 26 processes, and 40% of orthologs with 100 or more GO processes ( Figure S8A ).
27
Pleiotropy is more likely in proteins with many functions (He and Zhang, 2006), and the 28 subset of VIPs with many annotated GO processes has an excess of adaptation that is 29 very similar to the one observed when using all VIPs ( Figure S8B ). Adaptation to viruses 30 could thus have affected the evolution of host phenotypes in unexpected ways. In this 31 respect, it is particularly intriguing that VIPs have experienced highly increased rates of 32 adaptation within host functions such as development or neurogenesis (Table S3 ). way that appears independent of specific functions in the GO analysis. We argue that 5 grouping genes together based on the way they interact with diverse pathogens or other 6 environmental stimuli might be a profitable way for discerning the nature of selective 7 pressures that have molded animal genomes.
8
In conclusion, our analysis demonstrates that viruses have exerted a very powerful 9 selective pressure across the breadth of the mammalian proteome, and suggests the 10 possibility that pathogens in general are the key driver of protein adaptation in mammals 11 and likely other lineages and might have driven many pleiotropic effects on diverse 12 biological functions.
13
Methods
14
Manual curation of virus-interacting proteins 15
We identified 1,256 VIPs out of a total of 9,861 proteins with orthologs in the genomes of 16 the 24 mammals included in the analysis (Figure S1 and Tables S1 and S2). Annotation 
11
We created a permutation test that compares VIPs and non-VIPs with the same amount 12 of purifying selection. This is achieved by using the pN/pS ratio as a proxy for purifying 13 selection. See Supplemental Methods for details.
14
Retrieving of ANPEP mammalian coding sequences
15
We analyzed patterns of adaptation in ANPEP in a tree of mammals including 84 16 species. These species are the ones with annotated, known or predicted mRNAs (Table   17 S11 for their Genbank identifiers). The coding sequences were extracted from the 18 mRNAs and aligned with PRANK.
19
Gene Ontology-matching control samples
20
We created a permutation scheme that compares VIPs with random samples of non- Classic MK test (Supplemental Methods) for VIPs (blue dot) and non-VIPs (red dot and 8 95% confidence interval) for the ten viruses with 50 or more VIPs. F) Same as E) but for 9 the 20 top high level GO processes with the most VIPs below the dotted black line.
10
Above the dotted black line: the classic MK test for all VIPs, for non-immune VIPs and 11 for immune VIPs (Table S4 ). See also Tables S3, S4 Within the contact interface plus a given number of neighboring amino acids (one, five, 7 ten or 20 in the figure), adaptation excess (y axis) is defined as the number of observed 8 codons with a MEME P-value lower than the P-value threshold on the x axis, divided by 9 the average number of codons under the same P-value threshold obtained after
